Cytokinetics
CYTK
CYTK
136 hedge funds and large institutions have $465M invested in Cytokinetics in 2017 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
26% more funds holding
Funds holding: 108 → 136 (+28)
10.64% more ownership
Funds ownership: 68.21% → 78.84% (+11%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
136
Holding in Top 10
–
Calls
$5.24M
Puts
$2.35M
Top Buyers
| 1 | +$38.8M | |
| 2 | +$32.5M | |
| 3 | +$15.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.98M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$12.5M | |
| 3 | -$8.75M | |
| 4 |
Millennium Management
New York
|
-$4.39M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.76M |